Navigation Links
AdCare Health Systems Selects Remedi SeniorCare for Long-Term Care Pharmacy Solutions
Date:10/18/2011

BALTIMORE, Oct. 18, 2011 /PRNewswire/ -- Ohio-based AdCare Health Systems, Inc. (NYSE Amex: ADK) has selected Remedi SeniorCare®, one of the nation's largest institutional pharmacy companies, to provide comprehensive pharmacy and consulting services for AdCare's facilities  that deliver long-term care to approximately 443 residents in the Ohio region.

Remedi pharmacy services will include pharmacist consulting, daily medication and supply delivery, cost management and billing support, along with 24/7 clinical support for AdCare's skilled nursing and assisted living facilities. These services will be delivered by Remedi's pharmacy in Covington, Ohio, and beginning next year, will include Remedi's industry-leading Paxit™ med-pass solution.

Paxit med-pass helps long-term care organizations increase accuracy, save time, decrease cost and medication waste, and ultimately help improve care for residents. Its automated, centralized dispensing technology replaces the traditional "bingo card" method that requires time-consuming and often frustrating manual dispensing by nurses. Paxit delivers a 24-hour unit-dose cycle of medications contained in a secure, easy to open bag labeled with instructions and medication information.

AdCare will also have access to Remedi's on-line portal, My Remedi®, which features:

  • Real-time information for operational, clinical and financial data that enables effective decision making in all areas of facility operations;
  • RapidResponse®, 24/7/365 access to expert consultant pharmacists who provide hands-on support with medication regimen;
  • Reviews and solutions for improving clinical outcomes;
  • Flexible, multiple daily delivery schedules;
  • New admission/stat order deliveries;
  • Nurse account managers who provide facility training and clinical consultation;
  • 24/7 customer service;
  • Survey, compliance and audit assistance; and,
  • Billing representatives to work closely with facility business offices to ensure proper census management and accurate billing.

"We chose Remedi because we found their comprehensive pharmacy solutions to be unparalleled, particularly their expert support, service delivery technology and competitive pricing," said Sharon Reynolds, senior vice president of AdCare's Midwest nursing home operations. "We're looking forward to working with Remedi, and using Paxit and My Remedi to generate cost savings, as well as provide the best safety and quality of life for our residents."

Melissa Willis, Remedi's general manager of the Ohio region, commented: "We are excited to work with AdCare, a recognized innovator in LTC facilities. We are proud that we can provide AdCare something that nobody else in their market offers, which is Paxit, our own innovative solution for efficient and accurate med-passes. We are confident we can help AdCare achieve outstanding care, medication safety and operational efficiencies."

About AdCare Health Systems

AdCare Health Systems, Inc. (NYSE Amex: ADK) is a recognized innovator in senior living and health care facility management. AdCare develops, owns and manages assisted living facilities, nursing homes and retirement communities, as well as provides home health care services. Since its inception in 1988, AdCare's mission has been to provide the highest quality of healthcare services to the elderly. Since the fall of 2009, the company has pursued an aggressive M&A program. Combining its first quarter 2011 revenue with transactions currently in the process of closing, AdCare's estimated annualized revenue run-rate is expected to exceed $268 million. This would represent an increase of more than 400% over the company's revenues in 2010, and an increase of more than 900% over revenues in 2009 when it initiated its M&A campaign. For more information about AdCare, go to www.adcarehealth.com.

About Remedi SeniorCare

Remedi SeniorCare®, an innovative long-term care pharmacy provider, enables long-term care facilities to deliver better business results and provide exceptional resident-centered care. At the forefront of implementing high-tech advancements for the industry, Remedi redefined medication administration and management with the launch of the Paxit™ automated medication dispensing system delivering superior accuracy, efficiency and medication cost reduction.  Remedi's online and electronic tools via My Remedi™ web portal and Electronic Order Entry further drive business management efficiency and overall cost reduction.  Remedi supports nearly 25,000 residents across eight states with RapidResponse(SM) customer service, ensuring prompt access to medication delivery, expertise and comprehensive support. For more information and to learn about Remedi's pharmacy services, visit www.RemediRx.com.


'/>"/>
SOURCE Remedi SeniorCare
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Tone Deafness Explained, from the Harvard Health Letter
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
8. ViroPharma to Present at Three Upcoming Healthcare Conferences
9. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
10. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
11. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... - Forecast to 2022" report to their offering. ... to date financial data derived from varied research sources to ... potential impact on the market during the next five years, ... of sub markets, regional and country level analysis. The report ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
(Date:6/24/2016)... ... ... Comfort Keepers® of San Diego, CA is excited to announce they are ... drive cancer patients to and from their cancer treatments. Comfort Keepers provides quality ... and ongoing independence. Getting to and from medical treatments is one of the ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented ... in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... pluripotent stem (iPS) cells and other difficult to transfect cells, announces its launch ... PluriQ™ G9™ Gene Editing System is a complete system for culturing ...
Breaking Medicine News(10 mins):